Ethnicity and Cutaneous Melanoma in the City of Sao Paulo, Brazil: A Case-Control Study

Carregando...
Imagem de Miniatura
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Citação
PLOS ONE, v.7, n.4, article ID e36348, 7p, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Over the last century the incidence of cutaneous melanoma has increased worldwide, a trend that has also been observed in Brazil. The identified risk factors for melanoma include the pattern of sun exposure, family history, and certain phenotypic features. In addition, the incidence of melanoma might be influenced by ethnicity. Like many countries, Brazil has high immigration rates and consequently a heterogenous population. However, Brazil is unique among such countries in that the ethnic heterogeneity of its population is primarily attributable to admixture. This study aimed to evaluate the contribution of European ethnicity to the risk of cutaneous melanoma in Brazil. Methodology/Principal Findings: We carried out a hospital-based case-control study in the metropolitan area of Sao Paulo, Brazil. We evaluated 424 hospitalized patients (202 melanoma patients and 222 control patients) regarding phenotypic features, sun exposure, and number of grandparents born in Europe. Through multivariate logistic regression analysis, we found the following variables to be independently associated with melanoma: grandparents born in Europe-Spain (OR = 3.01, 95% CI: 1.03-8.77), Italy (OR = 3.47, 95% CI: 1.41-8.57), a Germanic/Slavic country (OR = 3.06, 95% CI: 1.05-8.93), or >= 2 European countries (OR = 2.82, 95% CI: 1.06-7.47); eye color-light brown (OR = 1.99, 95% CI: 1.14-3.84) and green/blue (OR = 4.62; 95% CI 2.22-9.58); pigmented lesion removal (OR = 3.78; 95% CI: 2.21-6.49); no lifetime sunscreen use (OR = 3.08; 95% CI: 1.03-9.22); and lifetime severe sunburn (OR = 1.81; 95% CI: 1.03-3.19). Conclusions: Our results indicate that European ancestry is a risk factor for cutaneous melanoma. Such risk appears to be related not only to skin type, eye color, and tanning capacity but also to others specific characteristics of European populations introduced in the New World by European immigrants.
Palavras-chave
Referências
  1. Acton RT, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-47
  2. Bakos L, 2009, J EUR ACAD DERMATOL, V23, P304, DOI 10.1111/j.1468-3083.2008.03027.x
  3. Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477
  4. Breslow NE, 1980, IARC SCI PUBL, V32
  5. Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166
  6. CLARK WH, 1969, CANCER RES, V29, P705
  7. Cust AE, 2009, AM J EPIDEMIOL, V170, P1541, DOI 10.1093/aje/kwp307
  8. de Paula Correa Marcelo, 2010, Photochem Photobiol, V86, P438, DOI 10.1111/j.1751-1097.2009.00659.x
  9. de Vries E, 2005, EUR J CANCER, V41, P2150, DOI 10.1016/j.ejca.2005.04.042
  10. Edge SB, 2010, AJCC AM JOINT COMMIT
  11. Eide MJ, 2005, ARCH DERMATOL, V141, P477, DOI 10.1001/archderm.141.4.477
  12. FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869
  13. Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034
  14. Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341
  15. Goncalves FT, 2011, J DERMATOL SCI, V64, P59, DOI 10.1016/j.jdermsci.2011.06.003
  16. Gruber F, 2008, COLLEGIUM ANTROPOL, V32, P147
  17. Hu S, 2004, ARCH DERMATOL, V140, P819, DOI 10.1001/archderm.140.7.819
  18. IBGE-Instituto Brasileiro de Geografia Estatistica, 2000, BRAS 500 AN POV
  19. Khan SG, 2002, NUCLEIC ACIDS RES, V30, P3624, DOI 10.1093/nar/gkf469
  20. Lascano AR, 2004, MEDICINA-BUENOS AIRE, V64, P504
  21. Li CY, 2006, CANCER EPIDEM BIOMAR, V15, P2526, DOI 10.1158/1055-9965.EPI-06-0672
  22. Loria D, 2001, INT J DERMATOL, V40, P108, DOI 10.1046/j.1365-4362.2001.01132.x
  23. MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252
  24. Mendes GLQ, 2010, J TOXICOL ENV HEAL A, V73, P850, DOI 10.1080/15287391003744757
  25. Millikan RC, 2006, CARCINOGENESIS, V27, P610, DOI 10.1093/carcin/bgi252
  26. Nijsten T, 2005, J EUR ACAD DERMATOL, V19, P332, DOI 10.1111/j.1468-3083.2005.01196.x
  27. Ou-Yang H, 2004, J INVEST DERMATOL, V122, P492, DOI 10.1046/j.0022-202X.2004.22247.x
  28. Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063
  29. Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003
  30. Sturm R. A., 2009, HUM MOL GENET, V18, P9
  31. Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I
  32. Swan MC, 2003, MELANOMA RES, V13, P415, DOI 10.1097/01.cmr.0000056243.56735.e6
  33. Tomescu D, CARCINOGENESIS, V22, P403